Immumem Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Seed
  • (Upcoming)

  • Latest Deal Amount
  • $4M

  • Investors
  • 2

Immumem Therapeutics General Information

Description

Developer of cell-based therapies designed for the prevention of cancer relapse. The company's platform utilizes induced pluripotent stem cells to engineer memory T and NK cells, enabling patients with long-term immune surveillance against refractory solid tumors.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 447 Sutter Street
  • Suite 506-1405
  • San Francisco, CA 94108
  • United States
+1 (415)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 447 Sutter Street
  • Suite 506-1405
  • San Francisco, CA 94108
  • United States
+1 (415)

Immumem Therapeutics Timeline

20252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Immumem Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round $4M Upcoming Startup
4. Equity Crowdfunding Announced Startup
3. Accelerator/Incubator 29-Apr-2026 Completed Startup
2. Grant 16-Jul-2025 $75K Completed Startup
1. Grant $50K Completed Startup
To view Immumem Therapeutics’s complete valuation and funding history, request access »

Immumem Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cell-based therapies designed for the prevention of cancer relapse. The company's platform utilizes induced
Biotechnology
San Francisco, CA
2 As of 2026

South San Francisco, CA
 

Philadelphia, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Immumem Therapeutics Competitors (16)

One of Immumem Therapeutics’s 16 competitors is Allogene Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Allogene Therapeutics Formerly VC-backed South San Francisco, CA
Century Therapeutics Formerly VC-backed Philadelphia, PA
Kite Pharma Formerly VC-backed Santa Monica, CA
Nkarta Therapeutics Formerly VC-backed South San Francisco, CA
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
You’re viewing 5 of 16 competitors. Get the full list »

Immumem Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Immumem Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
LvlUp Ventures Accelerator/Incubator
ScaleReady Corporation
To view Immumem Therapeutics’s complete investors history, request access »

Immumem Therapeutics FAQs

  • When was Immumem Therapeutics founded?

    Immumem Therapeutics was founded in 2024.

  • Where is Immumem Therapeutics headquartered?

    Immumem Therapeutics is headquartered in San Francisco, CA.

  • What is the size of Immumem Therapeutics?

    Immumem Therapeutics has 2 total employees.

  • What industry is Immumem Therapeutics in?

    Immumem Therapeutics’s primary industry is Biotechnology.

  • Is Immumem Therapeutics a private or public company?

    Immumem Therapeutics is a Private company.

  • What is the current valuation of Immumem Therapeutics?

    The current valuation of Immumem Therapeutics is .

  • What is Immumem Therapeutics’s current revenue?

    The current revenue for Immumem Therapeutics is .

  • Who are Immumem Therapeutics’s investors?

    LvlUp Ventures and ScaleReady have invested in Immumem Therapeutics.

  • Who are Immumem Therapeutics’s competitors?

    Allogene Therapeutics, Century Therapeutics, Kite Pharma, Nkarta Therapeutics, and Adaptimmune Therapeutics are some of the 16 competitors of Immumem Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process